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Abstract: A fast and efficient approach was established to identify bacteria possessing the 
potential  to  biosynthesize  phenazines,  which  are  of  special  interest  regarding  their 
antimicrobial  activities.  Sequences  of  phzE  genes,  which  are  part  of  the  phenazine 
biosynthetic pathway, were used to design one universal primer system and to analyze the 
ability of bacteria to produce phenazine. Diverse bacteria from different marine habitats 
and belonging to six major phylogenetic lines were investigated. Bacteria exhibiting phzE 
gene  fragments  affiliated  to  Firmicutes,  Alpha-  and  Gammaproteobacteria,  and 
Actinobacteria.  Thus,  these  are  the  first  primers  for  amplifying  gene  fragments  from 
Firmicutes and Alphaproteobacteria. The genetic potential for phenazine production was 
shown for four type strains belonging to the genera Streptomyces and Pseudomonas as well 
as for 13 environmental isolates from marine habitats. For the first time, the genetic ability 
of  phenazine  biosynthesis  was  verified  by  analyzing  the  metabolite  pattern  of  all  
PCR-positive strains via HPLC-UV/MS. Phenazine production was demonstrated for the type 
strains known to produce endophenazines, 2-hydroxy-phenazine, phenazine-1-carboxylic acid, 
phenazine-1,6-dicarboxylic  acid,  and  chlororaphin  as  well  as  for  members  of  marine 
Actinobacteria. Interestingly, a number of unidentified phenazines possibly represent new 
phenazine structures. 
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1. Introduction 
Nature is a profitable source of pharmaceutically active substances covering the whole range of 
biological  activities  such  as  antimicrobial,  antitumoral,  antiparasitic  or  immunosuppressive  [1,2]. 
Various natural products or natural product-derived compounds have been approved as drugs or are 
undergoing clinical evaluation and registration [2,3]. Because the rediscovery rate of already known 
substances  in  standard  screening  approaches  is  high,  new  strategies  are  urgently  needed.  Genetic 
approaches for the detection of secondary metabolite pathways are promising tools for the selection of 
biosynthetically talented microorganisms. So far, main targets in this respect were genes encoding for 
polyketide synthases  (PKSs) or non-ribosomal peptide  synthetases  (NRPSs) [4,5]. By focusing on 
polyketides and non-ribosomal peptides other interesting compound classes such as phenazines have 
been neglected so far. Phenazines of natural or synthetic origin turned out to be good drug candidates 
and therefore are promising secondary metabolites [6]. They are heterocyclic, nitrogenous compounds 
that are substituted at different sites of the core ring system and therefore display a wide range of 
structural  derivatives  and  biological  activities.  More  than  100  biologically  active  (antibacterial, 
antifungal, antiviral, antitumor) phenazines from natural origin are known to date, synthesized mainly 
by  Pseudomonas  and  Streptomyces  species  [7].  Phenazines  produced  by  the  root-colonizing 
Pseudomonas  fluorescens  2–79  and  Pseudomonas  aureofaciens  30–84  are  good  examples  for 
congeners with promising biological activity, in this case inhibiting several fungal plant pathogens [8]. 
An economically successful phenazine is clofazimine (Lamprene®, Novartis), first described in 1957 
which was established as an antileprosy agent and exerts anti-inflammatory properties in controlling 
erythema nodosum leprosum reactions (Official FDA Drug label) [6] as well as other antimicrobial 
activities [9–11]. Clofazimine is a synthetic phenazine analogue belonging to the riminophenazines, a 
group  of  compounds  which  was  originally  discovered  in  lichens  [12,13].  Another  phenazine, 
bis(phenazine-1-carboxamide), acts as a potent cytotoxin and represents an interesting class of dual 
topoisomerase I/II directed anticancer drugs [14]. 
Although  principal  parts  of  the  phenazine  biosynthesis  (Figure  1)  and  their  genetics  are  
known  [15,16],  there  are  still  gaps  in  our  knowledge  and  the  phenazine  pathway  is  still  
hypothetical [17]. The function and gene products of phzC, phzE and phzD have been experimentally 
proven. These enzymes catalyze the conversion into 3-deoxy-D-arabino-heptulosonic acid 7-phosphate 
(DAHP), 2-amino-2-deoxyisochorismic acid (ADIC) and trans-2,3-dihydro-3-hydroxyanthranilic acid 
(DHHA) [17–20]. The phenazine core structure is synthesized subsequently by condensation of two 
molecules of 6-amino-5-oxocyclohex-2-ene-1-carboxylic acid [17]. Presumably, PhzF is responsible 
for the isomerization of DHHA [18]. By now, the function of the enzymes PhzA, PhzB and PhzG are 
almost enlightened [19] and their role in the condensation and rearrangement reactions to form PCA is 
demonstrated [17]. According to this information, the design of appropriate oligonucleotide probes and 
primers  was  possible.  Mavrodi  et  al.  (2010)  [21]  quite  recently  designed  four  different  pairs  of 
oligonucleotides on the basis of the phzF gene of the phenazine biosynthesis and investigated the 
diversity of phenazine producers mainly in soil-dwelling and plant-associated bacteria.  
In  particular  marine  bacteria  have  attracted  our  interest  to  search  for  promising  natural  
products [1,22–26]. Therefore, we have investigated the possible application of a genetic approach for 
the detection of new marine isolates using phzE gene fragments as markers for the ability to produce Mar. Drugs 2011, 9                      
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bioactive phenazines. In contrast to Mavrodi et al. (2010) [21], we wanted to design a more universal 
primer  system  able  to  study  a  wide  range  of  bacterial  groups  including  actinomycetes  and 
pseudomonades, in order to detect genes of phenazine production in unidentified new isolates without 
prior performance of a phylogenetic classification. 
Figure 1. Schematic representation of the phenazine biosynthesis pathway. 
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2. Results and Discussion 
The high diversity of microbes and their manifold biosynthetic capabilities offer a great potential 
for novel, bioactive secondary products. Genetic approaches such as the application of primer systems 
for  NRPS,  PKS  or  halogenases  are  efficient  methods  to  select  appropriate  strains  for  further  
analyses [27,28]. The screening of bacteria for the presence of phenazine genes significantly adds to 
these selection filters. We report here on a rapid universal genetic system for the discovery of bacteria 
that are able to produce phenazines. The suitability of this PCR based screening approach for the 
identification of phenazine producing bacteria was demonstrated. A gene fragment indispensable for 
phenazine biosynthesis (phzE) served as a template for primer generation. As positive controls the type 
strain of S. cinnamonensis, and three subspecies of Pseudomonas chlororaphis, which are all well 
known producers of phenazines, were included in this study. For control strains several phenazine 
biosynthesis gene sequences were available at the NCBI (e.g., AM384985, HM594285, AF007801). 
Altogether  168  bacterial  strains  (including  the  four  reference  organisms)  were  examined  for  the 
presence  of  phzE.  The  PCR  analysis  was  complemented  by  a  chemical  investigation  in  order  to 
demonstrate the expression of the biosynthesis genes and to confirm the production of phenazines as 
proof of concept. Mar. Drugs 2011, 9                      
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2.1. Design of Oligonucleotides to Search for phzE Phenazine Gene Fragments  
Former investigations were able to associate different steps of the phenazine biosynthetic pathway 
with the corresponding genes, e.g., phzC, phzD, phzE and phzF. The transformation from chorismate to 
2-amino-2-deoxyisochorismic  acid  (ADIC)  is  necessary  for  the  formation  of  the  core  structure  of 
phenazines  and  is  catalyzed  by  the  enzyme  PhzE.  Thus,  PhzE  is  a  key  enzyme  in  phenazine 
biosynthesis  and  the  corresponding  gene  phzE  is  suitable  for  primer  design.  Sequences  from  the 
phenazine  biosynthetic  pathway  for  Alpha-,  Beta-  and  Gammaproteobacteria,  Actinomycetes  and 
Firmicutes  are  available  at  the  homepage  of  the  National  Centre  for  Biotechnology  Information 
(NCBI) and known from literature [29,30]. To ensure the inclusion of only true phenazine sequences, 
oligonucleotide  primers  were  constructed  only  from  those  genes  known  to  be  involved  in  the 
biosynthesis of corresponding chemical substances. Two conserved sites occurred within the alignment 
of  phzE  sequences  (Figure  2),  which  had  a  distance  to  each  other  to  produce  fragments  of  an 
appropriate length. The degenerated primers phzEf (5‘-GAA GGC GCC AAC TTC GTY ATC AA-3‘) 
and phzEr (5‘-GCC YTC GAT GAA GTA CTC GGT GTG-3‘) were designed to amplify a highly 
conserved stretch of the phzE gene of approximately 450 bp. The comparison of the oligonucleotide 
sequences from designed phzEf and phzEr primers with known phenazine genes verified this stretch as 
highly specific for phzE genes. Because the basic phenazine gene cluster including the phzE gene is 
highly conserved and derivatization of the basic phenazine structure are made at a later stage in the 
biosynthesis, the constructed phzE primers are expected to detect genes of a large variety of different 
phenazine structures and are appropriate to search for unknown bacteria producing novel phenazines. 
Figure 2. Alignment of known phzE gene sequences. Marked blocks served as the basis 
for primer construction. 
 
2.2. Screening for phzE Gene Fragments with the Constructed Primers 
Genes belonging to the phenazine biosynthetic pathway were present in approximately 10% of the 
bacterial strains  analyzed.  PCR results of 13 (8%) out of 164 bacterial strains and four reference 
organisms were positive in regard to the presence of phzE gene fragments (Figure 3, Tables 1 and 2). 
The  investigated  bacteria  comprised  different  bacterial  phyla,  namely  Actinobacteria  (76), 
Bacteroidetes (2), Firmicutes (28) and Proteobacteria (62) (Table 1).  Mar. Drugs 2011, 9                      
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Figure  3.  PhzE  gene  fragment  amplification  of  selected  strains.  Lane  1  and  10:  1  kb  
DNA-ladder;  2:  positive  control  Pseudomonas  chlororaphis  subsp.  chlororaphis  DSM 
50083
T; 3: negative control (without template DNA); 4, 5, and 6: isolates H253, HB117, 
and LB129, respectively, exhibiting phzE fragments; 7, 8, and 9: isolates HB290, HB147, 
and LB164, respectively, exhibiting nor phzE fragments. 
 
Table  1.  Distribution  of  phzE  phenazine  genes  among  major  phylogenetic  groups  and 
phenazine production of cultures (number of strains). 
Phylogenetic group 
Number of strains 
Analyzed 
PCR amplification 
phzE gene positive 
Producing phenazines 
in culture 
Actinobacteria
a  76  11  11 
Bacteroidetes  2  0  0 
Firmicutes  28  1  0 
Alphaproteobacteria  21  2  0 
Betaproteobacteria  2  0  0 
Gammaproteobacteria
b  39  3  3 
In total  168  17  14 
a including control strain S. cinnamonensis. 
b including 3 control P. chlororaphis strains. 
Corresponding  gene  fragments  were  detected  in  11  strains  of  Actinobacteria,  one  strain  of 
Firmicutes and two strains of the Alphaproteobacteria. All sequences were similar to known phzE 
gene sequences in a range from 65% similarity (phzE of strain LB151 to phzE of P. chlororaphis, 
AAF17499)  to  95%  similarity  (phzE  of  strain  AB108  to  phzE  of  gene  from  S.  cinnamonensis, 
CAL34110)  (Table  2).  Regarding  the  environmental  isolates  none  of  the  strains  within  the 
Bacteroidetes,  Beta-  as  well  as  Gammaproteobacteria  could  be  shown  to  contain  phzE  in  PCR 
amplification.  This  was  unexpected,  because  among  the  36  gammaproteobacterial  isolates  18 
Pseudomonas strains were examined and our PCR approach was performed with primer sequences 
largely based on sequences from Pseudomonas strains known as producers of phenazines [16,31,32]. 
The  suitability  of  our  primer  set  to  detect  phenazine  genes  in  Pseudomonas  species  was  further 
demonstrated by performing a database search that matched perfectly several phenazine genes, e.g.,  Mar. Drugs 2011, 9                      
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P. chlororaphis (L48339), Pseudomonas sp. M18 (FJ494909), P. aeruginosa (FM209186, CP000744, 
CP000438, AE004091, AF005404). Anyhow, a study based on phzF sequences exhibited a hit ratio of 
100%  including  51  Pseudomonas  strains  [21].  Therefore,  all  18  pseudomonads  from  our  study 
exhibiting negative results using phzE primers were subjected to a genetic approach with phzF primers. 
While the PCR-amplification of phzE and phzF gene fragments of the control type strains was positive 
(Table 2), amplification of the investigated isolates failed. As an additional control experiment, crude 
extracts  of  six  Pseudomonas  strains  were  analyzed  by  HPLC-UV/MS.  Because  of  the  distinctive 
properties  of  phenazine  UV-absorption  spectra  the  presence  of  phenazine  metabolites  was  out  of 
question.  Additionally,  for  another  study  all  natural  products  from  two  of  the  investigated 
Pseudomonas  strains  were  isolated  and  chemically  identified.  No  phenazines  were  detected.  We 
conclude that the Pseudomonas strains analyzed in this study lack genes for phenazine production and 
are unable to produce phenazines. In agreement with this, the only known marine phenazine producing 
Pseudomonas species is P. aeruginosa [33–35], synthesizing almost always pyocyanin. In contrast, 
different  marine  streptomycetes  are  known  for  production  of  variable  phenazine  structures  [9]. 
Streptomyces  strains  in  this  study  are  the  most  productive  group  as  well.  While  Brevibacterium, 
Bacillus and Pelagibacter were known as marine phenazine producers [36–38], this is the first time 
that representatives of the genera Micromonospora, Kiloniella and Pseudovibrio were identified as 
marine phenazine producers as well. 
Table 2. Presence of phenazine biosynthesis genes in the strains investigated. Information 
on related type strains (according to 16S rRNA sequences) and sequence similarity of phzE 
genes to known phenazine genes is displayed. Length, similarity and original bearer of the 
genetic information of the phzE PCR products are also included. 
Strain no.  Next relative type strain 
and acc.-no.
a 
Phylum
b  Sequence 
length
c 
Related phenazine 
gene, acc.-no.
d, 
similarity  
and producer 
Strains used as   Positive control       
DSM 1042
T  Streptomyces cinnamonensis DSM 
1042
T; DQ462657 
A  127  phzE; CAL34110; 100%;  
S. cinnamonenis 
DSM 6698
T  Pseudomonas chlororaphis subsp. 
aureofaciens DSM 6698
T; 
AY509898 
GP  139  phzE: ADP21173; 100% 
P. chlororaphis 
phzF: ADP21174; 100% 
P. chlororaphis 
DSM 19603
T  Pseudomonas chlororaphis subsp. 
aurantiaca DSM 19603
T; DQ682655 
GP  137  phzE: ADP21173; 98% 
P. chlororaphis 
phzF: ADP21174 49% 
P. chlororaphis 
DSM 50083
T  Pseudomonas chlororaphis subsp. 
chlororaphis DSM 50083
T; Z76673 
GP  125  phzE; AAF17499; 92% 
P. chlororaphis 
phzF: AAF17500; 99% 
P. chlororaphis Mar. Drugs 2011, 9                      
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Table 2. Cont. 
Strain no.    Next relative type strain 
and acc.-no.
a 
Phylum
b  Sequence 
length
c 
Related phenazine 
gene, acc.-no.
d, 
similarity  
and producer 
Environmental   Isolates       
AB108  Pseudovibrio ascidiaceicola F423
T; 
AB175663 
AP  144  phzE; CAL34110; 95%;  
S. cinnamonenis 
HB117  Streptomyces fulvorobeus LMG 
19901
T; AJ781331 
A  141  phzE; AAF17499; 73%;  
P. chlororaphis 
HB122  Streptomyces luridiscabiei S63
T  
AF361784 
A  141  phzE; AAF17499; 74%;  
P. chlororaphis 
HB202  Streptomyces mediolani LMG 
20093
T; AJ781354 
A  91  phzE; NP_252903; 84%;  
P. aeruginosa 
HB253  Micromonospora matsumotoense 
IMSNU 22003
T; AF152109 
A  144  phzB; AAF17496; 67%;  
P. chlororaphis 
HB254  Micromonospora matsumotoense 
IMSNU 22003
T; AF152109 
A  140  phzE; AAF17499; 73%;  
P. chlororaphis 
HB291  Streptomyces fulvorobeus LMG 
19901
T; AJ781331 
A  140  phzE; AAF17499; 73%;  
P. chlororaphis 
LB066   Kiloniella laminariae LD81
T;  
AM749667 
AL  132  phzE; CAL34110; 91%;  
S. cinnamonenis 
LB114  Streptomyces flavogriseus DSM 
40323
T; AJ494864 
A  141  phzE; AAF17499; 79%;  
P. chlororaphis 
LB129  Streptomyces fimicarius ISP 5322
T; 
AY999784 
A  145  phzB; AAF17496; 75%;  
P. chlororaphis 
LB150  Streptomyces luridiscabiei S63
T;  
AF361784 
A  132  phzB; AAF17496; 74%;  
P. chlororaphis 
LB151  Streptomyces griseus ATCC51928
T; 
AF112160 
A  133  phzE; AAF17499; 65%;  
P. chlororaphis 
a NCBI accession number. 
(all sequences were at least 98.5% similar to the corresponding type strain). 
b A = Actinobacteria, AP = Alphaproteobacteria, GP = Gammaproteobacteria, F = Firmicutes. 
c Given is the number of amino acids. 
d NCBI accession number. 
2.3. Detection of Phenazines in the phzE Positive Strains 
To demonstrate the synthesis of phenazines in all phzE positive strains, cultures of these strains 
were extracted and analyzed by HPLC-UV/MS analyses. 14 out of 17 of these strains were able to 
produce one or more substances with molecular masses and UV-spectra similar to known phenazines 
(Table  3,  Figure  4a–c).  In  S.  cinnamonensis  DSM  1042
T  the  production  of  endophenazines  A–C 
(Figure 5) and phenazine-1,6-dicarboxylic acid [15] could be demonstrated (Figure 3a). The metabolite 
chlororaphin  was  discovered  from  Pseudomonas  chlororaphis  subsp.  chlororaphis  DSM  50083
T.  
2-hydroxy-phenazine  (Figure  5)  and  phenazine-1-carboxylic  acid  were  produced  by  Pseudomonas 
chlororaphis subsp. aureofaciens DSM 6698
T and Pseudomonas chlororaphis subsp. aurantiaca DSM Mar. Drugs 2011, 9                      
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19603
T. In addition, the presence of senacarcin A (strain Streptomyces sp. HB117), saphenyl ester D, 
aestivophoenin C and a derivative thereof (strains Streptomyces sp. HB122 and HB291) as well as 
phencomycin  methyl  ester  and  1-carboxymethyl  phenazine  from  strain  Streptomyces  sp.  LB129 
(Figure 3b) were identified. 
All  environmental  isolates  producing  phenazines  (6%)  were  marine  Streptomyces  sp.  or 
Micromonospora sp. strains. Most of these strains produced both known phenazines and phenazines 
which did not show any accordance to a database entry. In total, 22 known phenazines were identified. 
In the case of strain Streptomyces sp. HB202 (Figure 4c), the production of streptophenazines A-H was 
verified using NMR spectroscopic analyses [39]. The large number of Streptomyces strains containing 
phzE genes is in good agreement with previous reports describing streptomycetes as a rich source for 
phenazines [9,15,39,40].  
Table 3. Known and putative novel phenazines from the strains studied. 
Strain no.  Next relative type 
strain 
[M
+]  UV absorption 
maxima (nm)
a  
Dereplication of phenazines 
Strains used as   positive control       
DSM 1042
T  Streptomyces 
cinnamonensis DSM 1042
T 
206 
224 
327, 249, 212 
371, 249, 215 
no hit in database 
phenazine-1-carboxylic acid [41] 
    268  375, 256, 223  phenazine-1,6-dicarboxylic acid [15] 
    292  371, 254, 214  endophenazine A [15]
 c 
    306  387, 269, 211  no hit in database 
    308  372, 249, 212  endophenazine C [15] 
    322  375, 256, 223  endophenazine B [15]
c 
    336  372, 249, 212  no hit in database 
DSM 6698
T  Pseudomonas chlororaphis 
subsp. aureofaciens DSM 
6698
T 
196 
224 
368, 257, 219 
371, 249, 215 
2-hydroxy-phenazine [42]
  
phenazine-1-carboxylic acid [41] 
DSM 19603
 T  Pseudomonas chlororaphis 
subsp. aurantiaca DSM 
19603
T 
196 
224 
368, 257, 219 
371, 249, 215 
2-hydroxy-phenazine [42]
c  
phenazine-1-carboxylic acid [41]
c 
DSM 50083
 T  Pseudomonas chlororaphis 
subsp. chlororaphis DSM 
50083
T 
223  370, 248, 213   chlororaphin [43] 
Environmental   Isolates       
HB117  Streptomyces fulvorobeus 
LMG 19901
T 
494 
512 
370(br), 274, 224 
370(br), 275, 230 
Senacarcin A 
saphenyl ester D [29] 
HB122  Streptomyces luridiscabiei 
S63
T  
492 
496 
376, 275, 235sh 
438sh, 383(br), 276, 
227 
saphenyl ester D [29] 
no hit in database 
    498  419sh, 393-325, 289, 
253sh, 220 
no hit in database 
    508  376, 275, 235sh  no hit in database 
    510  430(br), 325, 224  derivative of aestivophoenin C [44] Mar. Drugs 2011, 9                      
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Table 3. Cont. 
Strain no.  Next relative type 
strain 
[M
+]  UV absorption 
maxima (nm)
a  
Dereplication of phenazines 
    512  432(br), 327, 226  aestivophoenin C [44] 
HB202  Streptomyces mediolani 
LMG 20093
T 
396  368, 364sh, 351sh, 252, 
218 
streptophenazines E [39]
c 
    410  371, 364sh, 354sh, 252, 
213 
streptophenazines C [39]
  
    410  368, 364sh, 351sh. 252, 
218 
streptophenazines D [39]
c 
    424  367, 363sh, 350sh, 252, 
215 
streptophenazines A [39]
  
    424  368, 364sh, 351sh, 252, 
218 
streptophenazines B [39]
c 
    438  368, 364sh, 353sh, 252, 
215 
streptophenazines F [39]
c 
    438  368, 363sh, 351sh, 252, 
214 
streptophenazines G [39]
  
    440  368, 363sh, 352sh, 252, 
215 
streptophenazines H [39]
  
HB253  Micromonospora 
matsumotoense IMSNU 
22003
T 
260 
465 
566 
458, 302sh, 261, 232 
362sh, 345, 299, 221 
362sh, 345, 299, 221 
no hit in database 
no hit in database 
no hit in database 
HB254  Micromonospora 
matsumotoense IMSNU 
22003
T 
451 
 
 
361, 343, 352, 301, 223 
 
no hit in database 
 
 
HB291  Streptomyces fulvorobeus 
LMG 19901
T 
492 
496 
376, 275, 235sh 
438sh, 383(br), 276, 
227 
saphenyl ester D [29] 
no hit in database 
    498  419sh, 393-325, 289, 
253sh, 220 
no hit in database 
    508  376, 275, 235sh  no hit in database 
    510  430(br), 325, 224  derivative of aestivophoenin C [44] 
    512  432(br), 327, 226  aestivophoenin C [44] 
LB114  Streptomyces flavogriseus 
DSM 40323
T 
n.d.
b 
n.d.
b 
370, 270, 244 
419, 367, 305, 228 
no hit in database 
no hit in database 
LB129  Streptomyces fimicarius ISP 
5322
T 
296 
238 
366, 249, 214 
366, 249, 214 
phencomycin methyl ester [9] 
1-carboxymethyl phenazine 
LB150  Streptomyces luridiscabiei 
S63
T 
510  sh401, 378, 274, 227  no hit in database 
LB151  Streptomyces griseus  
ATCC 51928
T 
510  sh401, 378, 274, 227  no hit in database 
a sh, shoulder, br, broad. 
b n.d., not detectable. 
c substance
 was isolated by prepHPLC and structure was identified by UV-MS and 
1H NMR analysis (data 
not shown). Mar. Drugs 2011, 9                      
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Figure 4. (a) UV/MS-chromatogram (black line: MS; green line: UV at 250 nm) of a 17  
day-old  GYM  agar  plate  of  strain  Streptomyces  cinnamonensis  DSM  1042
T. 
Endophenazine A-C, phenazine-1-carboxylic acid, phenazine-1,6-dicarboxylic acid and an 
unknown  phenazine  substance  were  detected  as  well  as  naphterpin  and 
furanonaphthachinon  I;  (b)  UV/MS-chromatogram  (black  line:  MS;  green  line:  UV  at  
250 nm) of a 17 day-old GYM agar plate of Streptomyces strain LB129. 1-carboxymethyl 
phenazine and phencomycin methyl ester were detected; (c) UV/MS-chromatogram (black 
line: MS; green line: UV at 250 nm) of a 17 day-old GYM agar plate of strain HB202. 
Different streptophenazines and the aromatic polyketide mayamycin were detected. 
 
 
 
a
   
A 
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Figure 5. Structures of selected phenazines produced by Pseudomonas chlororaphis subsp. 
chlororaphis DSM 50083
T and Streptomyces cinnamonensis DSM 1042
T. 
 
In  nine  of  the  culture  extracts  a  total  of  13  different  substances  showed  typical  phenazine  like  
UV-absorption spectra, but gave no hit in the databases concerning UV and mass data. This indicates the 
presence of unidentified and possibly new natural phenazine products which warrant further investigation. 
For some of the identified phenazines interesting biological activities were reported. Senacarcin A 
is known for its activity against Gram-positive bacteria and tumor cell lines [45] and aestivophoenin C 
has antioxidative activity and acts as a neuronal cell protecting substance [44]. Interesting bioactivities 
of phenazines are also known from the marine Streptomyces sp. strain HB202, which produced several 
streptophenazines with activity against Gram-positive bacteria [39]. 
We expect that investigation of other so far unidentified phenazines from marine Actinobacteria is a 
remunerative challenge. Interestingly, phenazines were not detected in culture extracts of phzE positive 
strains of Alphaproteobacteria and Firmicutes. Though, all bacteria containing a phzE phenazine gene 
fragment have the capability to synthesize the phenazine core structure, proof of gene fragments from 
a  biosynthetic  pathway  does  not  give  evidence  of  the  integrity  of  corresponding  gene  cluster. 
Additionally, the expression of a gene cluster under conditions used is not warranted. Therefore, it is 
most likely that the cultivation conditions used were not appropriate for the production of some of the 
phenazines and have to be modified for the selected strains by our genetic approach in further studies.  
3. Experimental Section 
3.1. Bacterial Strains and Their Phylogenetic Affiliation 
166 bacterial strains used in this study were of diverse phylogenetic affiliation and were isolated from 
Halichondria panicea  (HB strains) [46] and  Saccharina latissima (synonym  Laminaria saccharina)  
(LB strains) [47] collected at the Kiel Fjord, Germany, and also from different sponges collected from 
the Adriatic Sea near Rovinj, Croatia (AB strains).  The strains belong to six different phylogenetic 
groups (Table 1). Additionally, type strains known to produce phenazines were used as positive controls: 
Streptomyces cinnamonensis DSM 1042
T, Pseudomonas chlororaphis subsp. chlororaphis DSM 50083
T, 
Pseudomonas  chlororaphis  subsp.  aureofaciens  DSM 6698
T,  and  Pseudomonas  chlororaphis  subsp. 
aurantiaca  DSM  19603
T.  For  S.  cinnamonensis  DSM  1042
T  phenazine  gene  sequences  and  the 
production  of  different  endophenazines  and  PCA  (phenazine-1-carboxylic  acid)  have  been  
demonstrated [15]. P. chlororaphis subsp. chlororaphis produced chlororaphin [48], P. chlororaphis Mar. Drugs 2011, 9                      
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subsp.  aureofaciens  and  P.  chlororaphis  subsp.  aurantiaca  produces  2-hydroxy-phenazine  [42]  and 
phenazine-1-carboxylic acid [41], respectively. 
For identification of the strains 16S rRNA gene sequence analyses were carried out according to  
Thiel  et  al.  2007  [49].  Comparison  of  the  16S  rDNA  sequences  was  performed  using  the  EMBL 
nucleotide database available at the European Bioinformatics Institute homepage using the Basic Local 
Alignment Search Tool (nucleotide blast) [50] and the Ribosomal Database Project (RDP) database [51]. 
3.2. Design of Oligonucleotides for Molecular Detection of phzE Phenazine Gene Fragments 
For the primer construction, amino acid sequences and nucleotide sequences of different phzE genes 
were retrieved from the European Bioinformatics Institute homepage and aligned using the program 
CLUSTAL_X [52]. Nucleotide sequences were deduced from amino acid sequences. The alignment 
was analyzed manually. The following phzE sequences were used for primer design: Streptomyces 
cinnamonensis  (AM384985/CAL34110/68793…70757;  putative  2-amino-2-desoxy-isochorismate 
synthase),  Pseudomonas  chlororaphis  PCL1391  (AF195615/AAF17499/4873…6786;  
phenazine-1-carboxamide),  Pseudomonas  aeruginosa  PAO1  (AF005404/AAC64488/3294…5177; 
pyocyanin),  and  Pseudomonas  aeruginosa  PAO1  (AE004091/AAG07601/4716660…4718543/ 
AAG05292/2073555…2075438;  phenazine  biosynthesis  protein  PhzE).  Primers  (Table  4)  were 
synthesized by MWG (Ebersbach, Germany). In order to check the specificity of the primers, the 
sequences of phzEf and phzEr were compared with sequences from the EMBL database using the 
Basic Local Alignment Search Tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi). This comparison revealed 
100% identity of the primers with corresponding sites of phenazine biosynthesis genes. Since Ashenafi 
et al. (2008) [53] reported that the anthranilate synthase (SvTrpEG) of Streptomyces venezuelae has a 
high  degree  of  amino  acid  sequence  similarity  to  the  phenazine  biosynthetic  enzyme  PhzE,  the 
corresponding nucleotide sequence (AF01267) was compared with the phzE primers using the bl2seq 
tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi). No significant similarity was found indicating that false 
positive results are excluded. 
Table 4. Primers used in this study. 
Primer  Sequence  Function  Ref. 
27f  5‘-GAGTTTGATCCTGGCTCAG-3‘  PCR of the 16S rRNA gene  [54]  
1492r  5‘-GGTTACCTTGTTACGACTT-3‘  PCR of the 16S rRNA gene  [54]  
534r  5‘-ATTACCGCGGCTGCTGG-3‘  Sequencing of the 16S rRNA gene  [55]  
342f  5‘-TACGGGAGGCAGCAG-3‘  sequencing of the 16S rRNA gene  [55]  
790f  5‘-GATACCCTGGTAGTCC-3‘  sequencing of the 16S rRNA gene  [50]  
phzEf  5‘-GAAGGCGCCAACTTCGTYATCAA-3‘  PCR and sequencing of phzE gene  this study 
phzEr  5‘-GCCYTCGATGAAGTACTCGGTGTG-3‘  PCR and sequencing of phzE gene  this study 
Ps_up1  5‘-ATCTTCACCCCGGTCAACG-3‘  PCR and sequencing of phzF gene  [21] 
Ps_low1  5‘-CCRTAGGCCGGTGAGAAC-3‘  PCR and sequencing of phzF gene  [21] Mar. Drugs 2011, 9                      
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3.3. Amplification and Identification of the Phenazine Gene Fragments 
The amplification reactions were carried out in a final volume of 25 µL. Taq DNA Polymerase 
(New England BioLabs, Ipswich, UK; MA, 5 U reaction
−1) with the ThermoPol Buffer Kit (New 
England BioLabs, Ipswich, UK; MA, USA) was applied. Primers phzEf and phzEr were deployed in a 
10  µM  concentration.  1  µL  of  a  preparation  containing  each  deoxynucleoside  triphosphate  at  a 
concentration of  2.5 mM was used. 10 to 50 ng DNA of all strains used in this study was employed  
as template.  
The amplification of the phzF gene sequence of the pseudomonads used in this study was performed 
using  puReTaq  Ready-To-Go  polymerase  chain  reaction  Beads  (Amersham  Biosciences,  Uppsala, 
Sweden) with the primers Ps_up1 and Ps_low1 [21]. Cycler conditions for both PCR experiments were 
as follows: Initial denaturation: 94 ° C for 120 s followed by 36 cycles of primer annealing at 54.7 ° C 
(phzE) and 57 ° C (phzF), respectively, for 60 s; primer extension at 72 ° C for 120 s and denaturation at 
94 ° C for 60 s. A final extension of 72 ° C for 420 s was performed. All PCR reactions were conducted 
in a T1 thermocycler (Whatman Biometra
®, Gö ttingen, Germany). Results of the amplifications were 
checked on a 1.5% agarose gel stained with ethidium bromide. DNA sequencing was done according 
to Wiese et al. [47]. The comparison of the phzE and phzF fragments, respectively, was done in the 
EMBL nucleotide database available at the European Bioinformatics  Institute homepage using the 
Basic Local Alignment Search Tool (blastx) [50]. 
3.4. Cultivation of phzE Strains 
3.4.1. Cultivation of phzE Positive Strain 
All  strains  with  a  positive  result  for  phenazine  gene  fragments  were  cultivated  for  subsequent 
chemical analysis of their cell extracts. They were grown on GYM agar plate (4 g glucose, 4 g yeast 
extract, 4 g malt extract, 2 g CaCO3, 15 g agar, 1 L water, pH 7.2) or MB agar plate (37.4 g Difco 
marine broth, 15 g agar, 1 L water, pH 7.2) at 28 ° C for 17 days as well as in 100 mL and 1000 mL 
GYM (4 g glucose, 4 g yeast extract, 4 g malt extract, 1 L water, pH 7.2) or MB medium (37.4 g Difco 
marine broth, 1 L water, pH 7.2) at 28 ° C and 120 rpm for seven days. The three P. chlororaphis 
strains were cultivated in 1000 mL King B medium [56] at 28 ° C and 120 rpm for 24 h. 
3.4.2. Cultivation of phzE Negative Strains  
All  strains  with  a  negative  result  for  phenazine  gene  fragments  were  cultivated  for  subsequent 
chemical analysis of their cell extracts. The precultures were grown on TSB medium agar plates (tryptic 
soy broth[Difco], 12 g/L; NaCl 20 g/L; agar 15 g/L) at 28 ° C for 1 day. A 1 cm
2 piece of the agar plate 
was used for inoculation of the main culture. Main cultures were grown in 100 mL TSB medium (with 
four baffles) and KingB medium [56] at 28 ° C and 120 rpm for one, three and six days. 
3.5. Culture Extracts of phzE Positive and Negative Strains 
For 1 L cultures the supernatants were separated from the cell mass pellets by centrifugation at 
4.700 ×  g for 20 min and extracted separately. Cells were homogenized by addition of 150 mL 96% Mar. Drugs 2011, 9                      
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EtOH and using Ultra-Turrax (IKA, Staufen, Germany) at 13,000 rpm for 30 s. The extracts were dried 
in vacuo and redissolved in MeOH for further analyses. Supernatants and the other cultures were 
extracted with EtOAc by homogenization with the help of Ultra-Turrax at 16,000 rpm for 30 s, also 
dried in vacuo and redissolved in MeOH for further analyses. 
3.6. Chemical Analysis of phzE Positive and Negative Strains 
Reversed  phase  HPLC  experiments  were  performed  using  a  C18  column  (Phenomenex  Onyx 
Monolithic C18, 100 ×  3.00 mm) applying an H2O (A)/MeCN (B) gradient with 0.1% HCOOH added 
to both solvents (gradient 0 min 5% B, 4 min 60% B, 6 min 100% B; flow 2 mL/min) on a VWR 
Hitachi Elite LaChrom system coupled to an ESI-ion trap detector (Esquire 4000, Bruker Daltonics). 
Dereplication  of  substances  was  realized  by  comparison  of  MS  and  UV  data  obtained  by  
HPLC-UV/MS analyses used data from the Antibase [57] and the Chapman & Hall/CRC Dictionary of 
Natural  Products  databases  [58].  For  endophenazines  A  and  B,  2-hydroxy-phenazine  and  
phenazine-1-carboxylic acid structure was confirmed by 
1H NMR analysis. 
3.7. Nucleotide Sequence Accession Numbers 
The  nucleotide  sequence  data  reported  in  the  present  study  were  deposited  in  the  GenBank 
nucleotide  sequence  database  under  the  accession  numbers  HM460698  (AB049),  HM460699 
(AB108),  AJ849545  (YIM  90018),  AM231308  (YIM  36723),  GQ863906  (HB117),  GQ863907 
(HB122),  GQ863918  (HB202),  GQ863921  (HB253),  GQ863922  (HB254),  GQ863926  (HB291), 
AM749667 (LB066), AM913982 (LB114), AM913952 (LB129), AM913970 (LB150) and AM913971 
(LB151) for 16S rRNA and HM460700-HM460715 for phzE gene fragments.  
4. Conclusions 
In conclusion, the application of the phzE primer system is a useful tool to indicate the presence of 
the phenazine biosynthetic pathway in various groups of bacteria. The proof of concept was shown for 
well known producers of phenazines, but also for marine Streptomyces sp. strain. This approach is 
particularly relevant, because many marine Actinobacteria turned out to be active phenazine producers 
and Streptomyces strains are known to synthesize phenazines with anticancer and/or anti-infective 
activities [59]. The method used in this study offers a promising method to test the ability of producing 
phenazines in new isolates of all kinds of bacteria including marine Actinobacteria. 
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